Canadian Sec - Delayed Quote CAD

NanoSphere Health Sciences Inc. (NSHS.CN)

0.0400
0.0000
(0.00%)
At close: May 16 at 12:38:42 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Cost of Revenue
53.6940
--
--
--
--
Gross Profit
-328.0370
--
--
--
--
Operating Expense
183.6480
183.6480
236.7930
283.8760
386.0010
Operating Income
-183.6480
-183.6480
-236.7930
-283.8760
-386.0010
Net Non Operating Interest Income Expense
-1.8780
-1.8780
0
0
0.0130
Other Income Expense
448.8580
448.8580
8.6660
2.1240
29.7180
Pretax Income
263.3320
263.3320
-228.1270
-281.7520
-356.2700
Net Income Common Stockholders
263.3320
263.3320
-228.1270
-281.7520
-356.2700
Diluted NI Available to Com Stockholders
263.3320
263.3320
-228.1270
-281.7520
-356.2700
Basic EPS
0.03
--
-0.02
-0.03
-0.05
Diluted EPS
0.03
--
-0.02
-0.03
-0.05
Basic Average Shares
10,275.2050
--
10,275.2050
10,275.2050
6,815.1000
Diluted Average Shares
10,275.2050
--
10,275.2050
10,275.2050
6,815.1000
Rent Expense Supplemental
54.1040
--
--
--
--
Total Expenses
183.6480
183.6480
236.7930
283.8760
386.0010
Interest Income
12.7170
--
--
0
0.0130
Interest Expense
1.8780
1.8780
0
--
-0.0130
Net Interest Income
-1.8780
-1.8780
0
0
0.0130
Net Income from Continuing & Discontinued Operation
263.3320
263.3320
-228.1270
-281.7520
-356.2700
Normalized Income
-118.1973
-118.1973
-236.7930
-283.8760
-385.9880
EBIT
265.2100
265.2100
-228.1270
-283.8760
-386.0010
EBITDA
265.2100
265.2100
-228.1270
-283.8760
-386.0010
Reconciled Cost of Revenue
53.6940
--
--
--
--
Reconciled Depreciation
--
--
--
--
0
Net Income from Continuing Operation Net Minority Interest
263.3320
263.3320
-228.1270
-281.7520
-356.2700
Total Unusual Items Excluding Goodwill
448.8580
448.8580
8.6660
2.1240
29.7180
Total Unusual Items
448.8580
448.8580
8.6660
2.1240
29.7180
Normalized EBITDA
-183.6480
-183.6480
-236.7930
-286
-415.7190
Tax Rate for Calcs
0.0002
0.0002
0
0
0
Tax Effect of Unusual Items
67.3287
67.3287
0
0
0
12/31/2021 - 8/15/2005

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BLT.NZ BLIS Technologies Limited
0.0150
+7.14%
 
ATRA Atara Biotherapeutics, Inc.
6.84
-10.12%
 
VIR Vir Biotechnology, Inc.
4.6000
+1.10%
 
NVAX Novavax, Inc.
6.73
+7.00%